Keyphrases
Type 2 Diabetic Patients
100%
Type 2 Diabetes Mellitus (T2DM)
54%
Hemoglobin A1c (HbA1c)
45%
Diabetes
44%
Insulin Therapy
39%
Metformin Therapy
31%
Copenhagen
31%
Carotid Intima-media Thickness (cIMT)
26%
Metformin
24%
Meta-analysis
24%
Insulin Analogues
21%
Sulfonylurea
21%
Systematic Meta-analysis
21%
Insulin
19%
Denmark
18%
Diabetic Patients
17%
Placebo
16%
Non-diabetic
15%
Body Mass Index
15%
Weight Gain
14%
Nutrition Therapy
14%
Hospitalization
12%
Pre-diabetes (pre-DM)
12%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
12%
Glucose-lowering Drugs
12%
Cardiovascular Outcomes
12%
Acute Myocardial Infarction
12%
Multicenter Trial
12%
Serum Levels
12%
Severe Hypoglycemia
11%
AIMS™
11%
Glycemic Control
11%
High Cardiovascular Risk
10%
Driven Approach
10%
Blood Flow Rate
10%
Heat-washout
10%
Patients with COVID-19
10%
Musculoskeletal Pain
10%
Mortality Outcomes
10%
Leisure-time Physical Activity
10%
Without Diabetes
10%
Renal Outcome
10%
Long-term Mortality
10%
Network Meta-analysis
10%
Nationwide Registry
10%
Metabolic Control
10%
Steroid Diabetes
10%
Diabetes Status
10%
Retinopathy
10%
Neuropathy
10%
Medicine and Dentistry
Patient with Type 2 Diabetes
68%
Maturity Onset Diabetes of the Young
49%
Hemoglobin A1c
44%
Glycon
37%
Insulin Derivative
34%
Intima-Media Thickness
25%
Meta-Analysis
24%
Diabetes
24%
Placebo
22%
Systematic Review
21%
Sulfonylurea
21%
Insulin Treatment
19%
Diabetes Mellitus
19%
Hypoglycemia
17%
Cardiovascular Disease
15%
Diet Therapy
14%
Acute Heart Infarction
12%
Type 2 Diabetes
11%
Low Density Lipoprotein Cholesterol
11%
Cross-Link
11%
Body Mass Index
11%
Glucagon-Like Peptide-1 Agonist
10%
Carbohydrate Diet
10%
Network Meta-Analysis
10%
Steroid Diabetes
10%
Dipeptidyl Peptidase-4 Inhibitor
10%
Hyperinsulinemia
10%
Glycation
10%
Cardiovascular Mortality
10%
Protamine
10%
Empagliflozin
10%
Advanced Glycation End-Product
10%
Glucocorticoid
10%
Achilles Tendon
10%
Patient with Type 1 Diabetes
10%
Diastolic Function
10%
Antidiabetic Agent
8%
Glycated Hemoglobin
8%
Insulin Detemir
7%
Insulin Aspart
7%
Glycemic Control
7%
Urinary System
7%
Myocardial Infarction
7%
Adverse Event
6%
Quality of Life
5%
Heart Failure
5%
Nephropathy
5%
Cardiovascular System
5%
Nursing and Health Professions
Patient with Type 2 Diabetes
65%
Hemoglobin A1c
44%
Metformin
31%
Insulin Derivative
31%
Arterial Wall Thickness
25%
Systematic Review
21%
Diabetes Mellitus
21%
Meta Analysis
21%
Placebo
20%
Body Mass
17%
Non Insulin Dependent Diabetes Mellitus
16%
Diet Therapy
14%
Glucose Blood Level
14%
Self Care
12%
Low Density Lipoprotein Cholesterol
11%
Prevalence
11%
Musculoskeletal Pain
10%
Alcohol Consumption
10%
Cohort Analysis
10%
Insulin Treatment
9%
Quality of Life
9%
Insulin Detemir
7%
Insulin Aspart
7%
Antidiabetic Agent
7%
Dietitian
7%
General Practitioner
7%
Adverse Event
6%
Practice Guideline
5%
Body Weight
5%
Factorial Design
5%
Cardiovascular Disease
5%
Glycosylated Hemoglobin
5%
